Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:21:31.559Z.
Calculation as of: 2026-10-06T17:21:31.559Z.
Quote observation: 2026-10-06T17:20:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d443e069440aa0ac5a32f25afa0d38c48efe58a411ec60778b8439bb1c5cf92a
EARNINGS YIELD
N/A
Eledon Pharmaceuticals, Inc.
Market Cap
$188.72M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$184.71M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$181.71M
Earnings Yield
92.57%
TTM Avg
50.31%
3Y Avg
28.59%
5Y Avg
28.59%
Market Cap
$175.80M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | $188.72M | N/A | N/A | N/A | N/A |
| RxSight, Inc. (RXST)vs › | $192.08M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $184.71M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $183.45M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $181.71M | 92.57% | 50.31% | 28.59% | 28.59% |
| Surrozen, Inc. (SRZN)vs › | $198.15M | N/A | N/A | N/A | N/A |
| Exagen Inc. (XGN)vs › | $199.44M | N/A | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $176.83M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.80M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $174.21M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
